Drug Shortage Report for SODIUM BICARBONATE INJECTION, USP
| Report ID | 124369 |
| Drug Identification Number | 02486628 |
| Brand name | SODIUM BICARBONATE INJECTION, USP |
| Common or Proper name | Sodium Bicarbonate Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | SODIUM BICARBONATE |
| Strength(s) | 42MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 4.2%, 2.5 mEq (mmol), 5 mL Vial |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-09-15 |
| Estimated end date | Unknown |
| Actual end date | 2020-12-05 |
| Shortage status | Resolved |
| Updated date | 2021-01-26 |
| Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to unforeseen circumstances, our Sodium Bicarbonate Injection, USP, 4.2%, 2.5 mEq (mmol), 5 mL Vial is on backorder, effective today. We are working with our production site to expedite receipt of our next shipment. UPDATE Available 12/05/2020 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-01-26 | French | Compare |
| v3 | 2021-01-26 | English | Compare |
| v2 | 2020-09-17 | French | Compare |
| v1 | 2020-09-17 | English | Compare |
Showing 1 to 4 of 4